MultiCell Technologies Inc (MCET)

[Odessa99]

Interesting Forbes article, with a point of view regarding companies in the same sphere as MultiCell:

"Still, the complex universe of biotechs is where potential giant winners are bred, as young companies with new promising medical ideas and technology undertake extensive research in search of undiscovered wonder drugs. After all, that’s where the Amgens and Gileads started before they rocketed to where they are today."

http://www.forbes.com/sites/genemarcial/2014/05/14/why-this-little-known-biotech-is-an-enticing-takeover-and-new-products-play/

The article goes on to make the following point:
"Noting that biotech acquisitions continue to rise, Benjamin says other companies in the industry that have been recently acquired, such as Santarius which Salix Pharmaceuticals (SLX%) bought in January 2014 for $2.6 billion, have been acquired at 6 to 10 times their 2014 projected revenues"

This recent Forbes article makes it clear that there is still a hot acquisition market for smaller biotech companies, and that the acquisition targets can be richly valued. All of this bodes well for companies like MultiCell, which hold valuable disease related patents and engage in associated clinical research.

As always, simply my opinion.

MCET